House Rx key facts
as of Oct 2026- Operator of a technology-enabled service company intended to make specialty medication more accessible and affordable.
- House Rx is valued at approximately $253.0M as of Oct 2026, set at its early-stage round, Nov 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $84.9M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($55.0M) in Nov 2025.
- Notable investors include Khosla Ventures, Bessemer Venture Partners, New Enterprise Associates, First Round Capital, Reform Ventures — 12 tracked in total.
- Status: Privately Held (backing).
Valued at $253.0M at its early-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch House Rx: the Monday email on marks, rounds and moves
House Rx funding rounds
1 roundsWho backs House Rx
12+House Rx valuation
House Rx was valued at $253 million at its early-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has House Rx raised?
House Rx has raised $84.9 million in total; 1 of its rounds is on record. The largest on record was a $55 million Series B in Nov 2025.
House Rx investors
12 investors are on record for House Rx, including Khosla Ventures, Bessemer Venture Partners, New Enterprise Associates and First Round Capital. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 growth equity firm. The Series B in Nov 2025 drew 6 investors.
Comparable companies
Comparable other healthcare technology systems names by valuation on PrivateMarketView: Paradigm Health (Healthcare Technology Systems) ($443 million), Big Health ($243 million) and SafelyYou ($206 million).
About House Rx
Operator of a technology-enabled service company intended to make specialty medication more accessible and affordable. The company partners closely with specialty clinics all over the country to deliver combined medical and pharmacy care to all patients, enabling clinics to dispense specialty medications to their patients, physicians, and pharmacists to collaborate on patient care.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 250
- Website
- houserx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.